The impact of CYP3A5*3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically‐based pharmacokinetic model

Por Emoto, Chie, Fukuda, Tsuyoshi, Venkatasubramanian, Raja, Vinks, Alexander A.
Publicado no Br J Clin Pharmacol (2015)

Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to Children

Por Hahn, David, Emoto, Chie, Vinks, Alexander A., Fukuda, Tsuyoshi
Publicado no Drug Metab Dispos (2017)

Using a Vancomycin PBPK Model in Special Populations to Elucidate Case‐Based Clinical PK Observations

Por Emoto, Chie, Johnson, Trevor N., McPhail, Brooks T., Vinks, Alexander A., Fukuda, Tsuyoshi
Publicado no CPT Pharmacometrics Syst Pharmacol (2018)

PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants

Por Emoto, Chie, Johnson, Trevor N., Neuhoff, Sibylle, Hahn, David, Vinks, Alexander A., Fukuda, Tsuyoshi
Publicado no CPT Pharmacometrics Syst Pharmacol (2018)

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Tra...

Por Khandelwal, Pooja, Emoto, Chie, Fukuda, Tsuyoshi, Vinks, Alexander A., Neumeier, Lisa, Dandoy, Christopher E., El-Bietar, Javier, Chandra, Sharat, Davies, Stella M., Bleesing, Jacob J., Jordan, Michael B., Mehta, Parinda A., Jodele, Sonata, Grimley, Michael S., Kumar, Ashish, Myers, Kasiani C., Marsh, Rebecca A.
Publicado no Biol Blood Marrow Transplant (2016)